ARTICLE | Distillery Therapeutics
Neurology
January 25, 2017 5:37 PM UTC
Cell culture and mouse studies suggest a modified ADCYAP1-derived peptide could help treat spinal and bulbar muscular atrophy (SBMA). In a mouse neuronal cell line expressing an SBMA-associated androg...
BCIQ Company Profiles